ORTHOWORLD.com
August 2017  
 
Now that we've collected 1H17 results from 20 publicly-traded companies, I'd like to share some performance-based observations. With just four months remaining in the year, these companies provide a helpful gauge for projecting industry growth.
 
Supplier companies have been involved in 17 of the 33 mergers and acquisitions that have closed in the orthopaedic space as of August 15. Record fundraising coupled with an attractive lending environment is expected to increase supplier M&A activity for the foreseeable future.


September issue



September issue



  Download 


 
Hip and knee surgeon Matthew Dietz, M.D. shares his take on challenges with present systems and devices, and offers thoughts on what he'd like to see in the future.
 
For the purpose of providing improved and predictive surgical outcomes, DePuy Synthes will begin co-marketing JointPoint's proprietary software in 2H17.
 
Mighty Oak Medical's FIREFLY guides can be used with any spinal deformity correction system, including OrthoPediatrics' RESPONSE scoliosis technology.

 
In its 10-Q filed on 8/8/17, Zimmer Biomet noted receipt of a subpoena from the U.S. Office of Inspector General which requests records related to healthcare professional consulting arrangements for the period spanning January 1, 2010 to the present.

 
Save the dates, June 12-14, 2018, but begin your search for new partners today using the Advanced Search features in the Exhibitor Listing pages.
 
The continual entry of new companies into the U.S. spine and trauma markets is not a surprise. Here are five companies--three of which are new to the U.S.--that recently received 510(k) clearance.
 
Pending FDA clearance, launch could occur within three years and would represent the first artificial meniscus to market.
 
Did you miss it?
Top Orthopaedic Device Companies: Ranking #6 to #15
Arthrex, DJO, NuVasive, Aesculap, Wright Medical, Globus Medical, ConMed, Orthofix, Exactech and Acumed range in annual revenue from $250 million to $2 billion and account for ~16% of the orthopaedic market's $48.1 billion. Unlike the Top 5, they each specialize within one or two segments of joint reconstruction, spine, arthroscopy/soft tissue and extremities.

www.BONEZONEpub.com